Interestingly, alternatively spliced isoforms of MYO18 A and NFYA have been linked to prognosis in breast cancer patients39,40, while FN1 is a critical component of the extracellular matrix that has been implicated in tumor progression and metastasis41. Here, NFYA is linked to breast carcinoma.